Medtech spin-out of Texas A&M University 3Scan secures $6.7m series A.

3Scan, a medtech spun-out of Texas A&M University in 2011, has raised $6.7m in its series A.

The funding, led by Lux Capital, will be used to support the development and eventual deployment of 3Scan’s primary technology, the Knife Edge Scanning Microscope (KESM). The KESM produces high-resolution images of tissues samples it cuts, and build a 3D reconstruction of the tissue that can be used to provide advanced images and analytics.

Todd Huffman, 3Scan founder and CEO, said: “While medical…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?